For decades, beauty had a straightforward enemy: ageing. Wrinkles were corrected, dark spots erased, skin tightened and youth bottled into increasingly expensive jars. Then the language changed. “Anti-ageing” became uncomfortable, even antiquated, as an industry increasingly concerned with inclusivity began embracing ideas of positive and healthy ageing.

The desire to stay youthful, however, never went away. It simply acquired a more sophisticated vocabulary.

Today, beauty speaks of “skin longevity”, “slow ageing”, “skinspan”, cellular rejuvenation, mitochondrial health and regeneration. Retinol now shares shelf space with peptides, growth factors and ingredients marketed around exosomes and NAD+. Beauty devices promise optimisation through light, while aesthetic clinics offer treatments designed not merely to correct what has already happened, but to intervene before visible ageing takes hold.

The proposition has subtly changed. Beauty is no longer promising consumers that they will never grow old. It is suggesting that they might be able to optimise how they age.

That could represent genuine progress. It could also be anti-ageing marketing with a far more intelligent name.

Ageing Has Become Big Business Again

There is certainly money waiting for whoever successfully sells the future of ageing.

McKinsey expects the global beauty market to reach USD 590 billion by 2030, growing around 5 per cent annually, with some of the strongest growth expected from emerging markets including Southeast and Central Asia.

Asia is particularly important to this evolution. NielsenIQ reported global beauty sales growth of 10 per cent in its 2025 State of Beauty report, while Asia-Pacific expanded 14.3 per cent, ahead of North America, Latin America and Europe. Online beauty sales in Asia-Pacific were growing by approximately 20 per cent, creating an ecosystem where new ingredients, technologies and terminology can travel extraordinarily quickly.

Meanwhile, the definition of beauty itself is expanding. Half of global consumers surveyed by NIQ said regular self-care had become more important than it was five years earlier; 44 per cent planned to take more vitamins or supplements, while 63 per cent placed greater importance on sleep. NIQ estimates that the intersection of wellness and ritual expands beauty’s potential market opportunity by 64 per cent.

The convergence is significantly important. Once skincare becomes wellness, and wellness becomes longevity, beauty is no longer confined to the bathroom cabinet or dressing table.

From Beauty Routine to Biological Maintenance

The modern longevity routine can encompass skincare, supplements, LED devices, nutrition, sleep, diagnostics and aesthetic medicine. Therefore, the consumer is encouraged to think differently about the face and body.

Rather than asking how to conceal a wrinkle, the question becomes what caused it biologically—and whether that process can be slowed. It is a particularly compelling proposition in Asia, where preventative skincare was culturally entrenched long before “longevity” became an industry buzzword.

Mintel identifies South Korea as a market helping drive the shift from anti-ageing towards “slow ageing”, particularly among Millennials and Gen Z interested in maintaining long-term skin health. Across Asia-Pacific, Mintel found mentions of “slow ageing” in anti-ageing facial skincare launches increased by 1,500 per cent over four years.

China offers another indication of increasingly ingredient-literate consumers: 34 per cent of Chinese consumers with sensitive skin surveyed by Mintel had either heard of retinol or purchased a product containing it as a main ingredient.

In India, meanwhile, 29 per cent of adults surveyed prioritised healthier skin as an anti-ageing benefit, equal to the proportion looking for pollution protection. Traditional anti-ageing claims are gradually declining as consumers move towards skin health, collagen support, firming and other positive-ageing language.

Perhaps biohacking did not introduce Asia to preventative beauty. It simply provided a new scientific vocabulary for something many consumers were already doing.

When Beauty Starts Looking Like Medicine

The more complicated question emerges when cosmetics begin borrowing not only medicine’s technology but its authority. Terms such as cellular repair, DNA damage, regeneration, growth factors and biostimulation lend products an air of clinical legitimacy. At the same time, the boundary separating a skincare routine from the aesthetic clinic is becoming increasingly porous.

The International Society of Aesthetic Plastic Surgery recorded close to 38 million surgical and nonsurgical aesthetic procedures worldwide in 2024, representing a 42.5 per cent increase from 2020. More than 20.5 million were nonsurgical procedures, including botulinum toxin, hyaluronic-acid fillers, skin tightening and chemical peels.

The affluent beauty consumer can now move seamlessly from serum to supplement, facial device to injectable—and increasingly regard them as components of the same maintenance programme.

For luxury beauty, that presents an extraordinary commercial opportunity. It also creates a responsibility to distinguish compelling science from compelling scientific language.

The Science May Not Always Move as Fast as the Marketing

Exosomes illustrate that controversy particularly well. These microscopic extracellular vesicles involved in cellular communication have attracted considerable interest in regenerative medicine and are increasingly appearing in discussions around skin and hair rejuvenation. Mintel itself identifies exosomes among innovations influencing longevity-led skincare.

But excitement should not be confused with universal clinical validation. The US Food and Drug Administration states that there are currently no FDA-approved exosome products intended to treat diseases or conditions, and has previously warned consumers about unapproved regenerative treatments marketed using exosome claims. That does not mean every cosmetic mentioning exosomes is equivalent to an unapproved medical treatment; it does underline the need to distinguish topical cosmetics, aesthetic procedures and regulated biological therapies rather than allowing one scientific term to blur all three.

Biohacking beauty therefore demands something consumers should already value: scrutiny. A higher price, futuristic ingredient or clinical-looking bottle does not automatically constitute stronger evidence.

Have We Really Made Peace With Ageing?

The irony is that longevity beauty arrives just as consumers appear increasingly interested in healthier definitions of beauty.

The movement towards skin health, wellbeing and prevention is arguably preferable to an industry relentlessly instructing people to “reverse” their age. There is merit in protecting skin, managing inflammation, sleeping better, exercising, eating well and making informed decisions about aesthetic interventions.

However, optimisation has its own psychological trap. Once every biological process can supposedly be measured, monitored and improved, ageing risks becoming another personal performance metric. A wrinkle is no longer merely a wrinkle; it becomes evidence that perhaps something in the routine has not been optimised sufficiently.

The beauty industry may have stopped telling consumers to fear getting older. The more uncomfortable question is whether it has replaced that fear with something even more demanding: the responsibility to age correctly.

Longevity could become beauty’s most intelligent evolution yet if its objective is healthier skin and better wellbeing over a longer lifetime. But if “anti-ageing” has merely become “biohacking”, the industry’s oldest insecurity has not disappeared. It has simply had a very expensive rebrand.

For more on the latest in wellness and beauty reads, click here.

The post Beauty Made Peace With “Anti-ageing”, Only To Begin Rewriting Its Biology appeared first on LUXUO.

​